Jason Valent, MD of Cleveland Clinic discusses how new novel agents are changing the management of amyloidosis at the 58th ASH Annual Meeting in San Diego, CA.
NEOD001 Set To Be Practice Changing for Amyloidosis
Jason Valent, MD of Cleveland Clinic discusses how new novel agents are changing the management of amyloidosis at the 58th ASH Annual Meeting in San Diego, CA.